Quest Diagnostics CFO to Address Leerink Conference Amid Sector Consolidation
Event summary
- Quest Diagnostics CFO Sam Samad will speak at the Leerink 2026 Global Healthcare Conference on March 11, 2026.
- The presentation will be a fireside chat and Q&A session, webcast live and archived.
- The conference is taking place in Miami.
- Quest Diagnostics serves approximately half of US physicians and hospitals and one in three American adults annually.
The big picture
The announcement highlights Quest Diagnostics' continued focus on investor relations as the diagnostic testing sector faces increasing pressure from larger healthcare providers and evolving reimbursement models. Leerink's conference is a key venue for communicating strategy and performance to institutional investors. The CFO's participation signals a desire to proactively address investor concerns and outline a path forward in a challenging environment.
What we're watching
- Market Positioning
- The CFO's comments will likely address the ongoing consolidation within the diagnostic testing market and how Quest Diagnostics intends to maintain its competitive position against larger players.
- Cost Pressures
- The webcast should reveal how Quest Diagnostics is managing cost pressures from payers and the impact on margins, particularly given the shift towards value-based care.
- Growth Strategy
- The presentation will provide insight into Quest Diagnostics' growth strategy beyond core testing, including potential expansion into new service lines or geographic markets.
Related topics